Kevin T. FitzGerald, SJ, PhD, PhD
School of Medicine, Omaha Campus
- Medical Humanities
- Associate Professor
- Kevin FitzGerald and Julia Shuster, “Ethics of Genetic Engineering,” in New Encyclopedia of Bioethics and Sexology, ed. Giovanni Russo, Elledici Publishing Co., Turin, Italy (January 2018, in Italian).
, Elledici Publishing Co., 2018
- “Forming Conscience in an Age of Radical Biomedical Discovery,” in Conscience and Catholic Health Care: From Clinical Contexts to Government Mandates, edited by David E. DeCosse and Thomas A. Nairn, OFM, ORBIS BOOKS, Maryknoll, NY, 2017., Orbis Press, 2017
- Fabia De Oliveira Andrade, Wei Yu, Xiyuan Zhang, Elissa Carney, Rong Hu, Robert Clarke, Kevin FitzGerald and Leena Hilakivi-Clarke, “Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model,”, Endocrine-Related Cancer, 26, No. 3., 1-15, 2019
- Mária Šuleková and Kevin FitzGerald, “Can the Thought of Teilhard de Chardin Carry Us Past Current Contentious Discussions of Gene Editing Technologies?”, Cambridge Quarterly, vol. 28, No.1, 2019
- Nina Zeldes, Hansjörg Dilger, Kevin FitzGerald, Niko Kohls, Eileen Moore, Eberhard Nöfer, and James Giordano, “Transnational Patients: Practical and Ethical Implications for Medical Practices and Health Promotions Policy,” doi: 10.1002/wmh3.263.
, World Medical & Health Policy, 2018
- Wayne Paris, PhD, LCSW; Rabbi Jerry H. Seidler, MAHL, JD, BCC; Kevin FitzGerald, S.J., PhD, PhD; Aasim I. Padela MD, MSc; Emanuele Cozzi, MD, PhD; David KC Cooper, MD, PhD, FRCS; "Jewish, Christian, and Muslim Theological Perspectives about Xenotransplantation," , doi.org/10.1111/xen.12400., Xenotransplantation, 2018
- FitzGerald K. “CRISPR: What Potential? What Peril? Who Decides?”
, Health Care Ethics USA, Vol. 25, No. 1., 2017
- FitzGerald, K. “Clinical Ethics Consultations,” Health Progress, September – October 2017., Health Progress, 2017
- Douglas C. McAdams, W. Kevin Conley II, Kevin T. FitzGerald, G. Kevin Donovan, “How We Should Conceive of Creation: Natural Birth as an Ethical Guidepost for Neonatal Rescue,”, American Journal of Bioethics, Vol17, Issue 8, 2017
- FitzGerald K. “A Catholic Perspective on Human Genome Editing,
, The National Catholic Bioethics Quarterly, Vol. 17, No. 1., 2017
- Rochelle E. Tractenberg, Kevin T. FitzGerald, and Jeff Collmann, “Evidence of Sustainable Learning from the Mastery Rubric for Ethical Reasoning,” doi:10.3390/educsci7010002, Education Sciences, 7(1), 2, 2017
- W. Kevin Conley II, Douglas C. McAdams, G. Kevin Donovan, and Kevin T. FitzGerald, “Beneficence In Utero: A Framework for Restricted Prenatal Whole-Genome Sequencing to Respect and Enhance the Well-Being of Children,”, American Journal of Bioethics, Vol. 17, No. 1., 2017
- “Health Promotion: Prevention, Enhancement or Selection?” Philosophical Café for Coburg University of Applied Sciences and Arts, Coburg, Germany.
- “Ethical Perspectives on Clinical Use of Germline Gene Editing,” panel moderator and participant, American Society of Gene & Cell Therapy Policy Summit, Washington, DC.
- “Direct-to-consumer Genomics: what is it, and what should it be?” Hawai’i Department of Health, Honolulu, HI.
- “Genomic Medicine: Rapidly Advancing, but Where and to What End?” Tripler Army Medical Center, Honolulu, HI.
- “A Catholic Guide to Genomic Medicine,” and "Inter-professional Ethics Education in the 21st Century," University of Monterrey, Monterrey, Mexico.
- “Human Genome Editing: Rapidly Advancing, but Where and to What End?” and Panelist for Homo technicus/technologicus: Biotechnology, Health Promotion and Ethics of Human Flourishing, International Symposium at Coburg University of Applied Sciences and Arts, Coburg, Germany.
Panelist, CRISPRcon: Conversations on Science, Society and the Future of Gene Editing, Boston, MA.
- Panelist, “Combating the Emergence and Spread of Antimicrobial Resistance: A Workshop to Strengthen Faith-Based Engagement,” U.S. State Department, DC., 2017
- “Catholic and Christian Views on Theological Issues Associated with Xenotransplantation,” International Xenotransplantation Association Annual Meeting, Baltimore, MD.
- “Promise and Peril of Genomic Medicine,” United Faculty for Life Annual Meeting, University of St. Thomas Law School, Minneapolis, MN.
- “The Virtue of Genomic Medicine,” 4th Annual Pellegrino Seminar, Georgetown University, Washington, DC.
Grant Funding Received
- GU Global Engagement International Collaborative Grant: What Do Direct-To-Consumer (DTC) Genetic Testing Companies Need To Do To Get This Business “Morally Right”? Bassem R. Haddad, Luc R. Wathieu, and Kevin T. FitzGerald, 2018-20.
- The Hastings Center: “Goals and Practices for Next-Generation Prenatal Testing” Project Working Group Member, 2014-18.
- GU Complex Moral Challenges Grant: Improving Female Genital Mutilation/Cutting Healthcare and Clinical Guidelines Through Community Engagement and Leadership, Kevin FitzGerald, SJ, PhD, PhD; Samantha Wu, BS; Ranit Mishori, MD, MHS, FAAFP; Rebecca Reingold, JD, 2016-18.
- Building the National Center for Infectious Disease Analysis (NCIDA): a collaboration among the public health departments of the District of Columbia, Maryland, New York State and Virginia with the Oak Ridge National Laboratory and Georgetown University. Ethics Principle Investigator, 2017-2018.
- Global Comprehensive and Integrative Medicine Project (Korea Federal Government and Daegu City Government funding with by Daegu Catholic University Medical Center): GU Program Director, November, 2012-July, 2018.
- “The Business of Direct-to-Consumer Genetic Testing: A Complex Moral Challenge,” Co-Principle Investigator, Georgetown University Complex Moral Challenges Grant (July 2015-June 2019).
- Global Engagement Faculty Committee International Collaborative Grant awarded to Drs. Kevin FitzGerald and James Giordano, “When in ‘Roam'...Transnational Patients: Practical and Ethical Implications for Medical Practices and Health Promotions Policy,” to bring together international scholars for a meeting on this topic. 2016-17.
- Consultant, 2015
- Consultor, 2014